Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Lambe

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|May 1, 1984
Isosorbide dinitrate plasma concentrations and bioavailability in human subjects after administration of standard oral and sublingual formulationsL F Chasseaud, A Darragh, E Doyle, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1983
Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulationsL F Chasseaud, E Doyle, T Taylor, et al.
Journal of Chromatography|May 13, 1983
Determination of heptaminol in human plasma and urine by high-performance liquid chromatographyR R Brodie, L F Chasseaud, L Rooney, et al.
Clinical Pharmacology and Therapeutics|May 1, 1984
Isosorbide 5-mononitrate kineticsR M Major, T Taylor, L F Chasseaud, et al.
Arzneimittel-Forschung|January 1, 1982
Isosorbide dinitrate pharmacokineticsT Taylor, L F Chasseaud, E Doyle, et al.
Biopharmaceutics & Drug Disposition|May 1, 1986
Pharmacokinetics and bioavailability of the anti-emetic agent bromoprideR R Brodie, L F Chasseaud, A Darragh, et al.
Arzneimittel-Forschung|January 1, 1983
[Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations]L F Chasseaud, T Taylor, R M Major, et al.
Biopharmaceutics & Drug Disposition|April 1, 1985
Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-stateT Taylor, L F Chasseaud, R M Major, et al.
Arzneimittel-Forschung|January 1, 1984
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]T Taylor, R M Major, F C Leaf, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1987
Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dogS G Wood, B A John, L F Chasseaud, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|May 1, 1984
Isosorbide dinitrate plasma concentrations and bioavailability in human subjects after administration of standard oral and sublingual formulationsL F Chasseaud, A Darragh, E Doyle, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1983
Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulationsL F Chasseaud, E Doyle, T Taylor, et al.
Journal of Chromatography|May 13, 1983
Determination of heptaminol in human plasma and urine by high-performance liquid chromatographyR R Brodie, L F Chasseaud, L Rooney, et al.
Clinical Pharmacology and Therapeutics|May 1, 1984
Isosorbide 5-mononitrate kineticsR M Major, T Taylor, L F Chasseaud, et al.
Arzneimittel-Forschung|January 1, 1982
Isosorbide dinitrate pharmacokineticsT Taylor, L F Chasseaud, E Doyle, et al.
Biopharmaceutics & Drug Disposition|May 1, 1986
Pharmacokinetics and bioavailability of the anti-emetic agent bromoprideR R Brodie, L F Chasseaud, A Darragh, et al.
Arzneimittel-Forschung|January 1, 1983
[Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations]L F Chasseaud, T Taylor, R M Major, et al.
Biopharmaceutics & Drug Disposition|April 1, 1985
Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-stateT Taylor, L F Chasseaud, R M Major, et al.
Arzneimittel-Forschung|January 1, 1984
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]T Taylor, R M Major, F C Leaf, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1987
Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dogS G Wood, B A John, L F Chasseaud, et al.
Pageof 3